Stay updated on KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new system revision (v3.4.2) was added to the history, and an existing government funding/operating status notice was removed; the previous revision (v3.4.1) remains listed. The changes are administrative in nature and do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check21 days agoChange DetectedA site-wide funding notice was added and the Record History shows a new revision label (v3.4.1). These updates are administrative and do not alter the trial data or study details.SummaryDifference0.9%

- Check28 days agoChange DetectedThe history page now shows a glossary option, green highlights for additions and red highlights for deletions, and an updated revision label (v3.4.0) with minor wording changes like 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check35 days agoChange DetectedThe Record History shows a new revision entry v3.3.4 and removes v3.3.3, reflecting a minor update to the historical record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the history and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed as maintenance updates; these do not affect study data or record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedThe footer now shows Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

Stay in the know with updates to KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.